Registrera för att skapa bevakningar för instrument,
ekonomiska händelser och innehåll av författare som följs
Gratis registrering Har du redan ett konto? Logga in
Värdering
Alla instrumenttyper
- Alla instrumenttyper
- Index
- Aktier
- ETF
- Fonder
- Råvaror
- Valutor
- Krypto
- Obligationer
- Certifikat
Prova en annan sökning
Nyhet! 💥 Skaffa ProPicks för att se strategin som har vunnit över S&P 500 med över 1,183 % Skaffa 40 % rabatt
Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class H2 Gbp (0P0000XRE3)
Lägg till/Ta bort från en portfölj
Lägg till portföljen
57,480
-0,220
-0,38%
Typ:
Fond
Marknad:
Storbritannien
Utgivare:
Janus Henderson Investors
ISIN:
IE00B8GQ0T69
Tillgångsklass:
Aktier
- Morningstar-värdering:
- Totala tillgångar: 3,82B
Janus Capital Funds plc - Janus Global Life Scienc
57,480
-0,220
-0,38%
- Översikt
- Profil
- Historiska data
- Innehav
0P0000XRE3 Översikt
På denna sida hittar du en djupgående profil av Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class H2 Gbp. Läs om viktig ledning, totala tillgångar, investeringsstrategi och kontaktinformation om 0P0000XRE3 tillsammans med annan information.
Investeringsstrategi
Fonden investerar i bolag som förvaltaren anser öka livskvalitet t.ex. medicin, forskning, bioteknik och hälsa. Fonden håller sig till Bloomberg L.P.s bolagskategorier för att förminska urvalet. (Alla euro-klasser valutasäkras upp till 100%, vilket betyder att ändringar i växelkursen dollar/euro inte påverkar fondens avkastning och att avkastningen blir högre om dollarn faller i värde mot euron.)
Kontaktinformation
Adress
201 Bishopsgate
London,London EC2M 3AE
United Kingdom
London,London EC2M 3AE
United Kingdom
Telefon
8002270486
Verkställande ledning
| Namn | Titel | Sedan | Till |
|---|---|---|---|
| Daniel Lyons | Portfolio Manager | 2023 | Nu |
| Biografi | Daniel Lyons is a Portfolio Manager on the Health Care and Biotech Teams at Janus Henderson Investors, a role he has held since 2018. He is also a Research Analyst on the US Small/Mid-Cap Growth Team since 2000 and focuses on biotechnology and life science tools sectors. Daniel started consulting for Janus in 1997 and joined the research team full time in 2000. Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 19 years of financial industry experience. | ||
| Andy Acker | Portfolio Manager | 2007 | Nu |
| Biografi | Andy Acker is a Portfolio Manager on the Health Care and Biotech Teams at Janus Henderson Investors. He is also the Health Care Sector Lead. Andy was an assistant portfolio manager from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience. | ||
| Ethan Lovell | Portfolio Manager | 2015 | 2022 |
| Biografi | Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. | ||
| Thomas R. Malley | Portfolio Manager | 2000 | 2007 |
| Biografi | Malley joined Janus Capital Corporation in 1991 and currently serves as a portfolio manager. Malley holds the Chartered Financial Analyst designation. | ||
Skriv dina tankar om Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class H2 Gbp
Aär du säker på att du vill ta bort det här diagrammet?
Radera Avbryt
Ersätt det bifogade diagrammet med ett nytt?
Byt ut Avbryt
Riktlinjer för kommentarer
Lägg till diagram till kommentar
Bekräfta blockering
Är du säker på att du vill blockera %USER_NAME%?
Genom att blockera kan du och %USER_NAME% inte se varandras inlägg på Investing.com.
%USER_NAME% lyckades läggas till i din Blockeringslista
Eftersom du precis avblockerat denna person måste du vänta 48 timmar för att kunna förnya blockeringen.
Rapportera den här kommentaren
Jag anser att denna kommentar är:
Kommentar flaggad
Tack!
Rapporten har skickats till våra moderatorer för granskning